Search Results 7151-7160 of 25480 for oral

  1. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    Inability to swallow oral medication. Pregnant and lactating women. WOCBP who tested positive in a serum pregnancy test within 24 hours prior to the first ...

  2. Urinary Incontinence Archives - Mayo Clinic News Network

    ... oral medicine, but they may not know there are treatments beyond oral medication if they're not having adequate symptom control," Dr. Linder says. "The ...

  3. Publications - Michael J. Marino, M.D. - Mayo Clinic

    Sinonasal Outcomes Using Oral Corticosteroids in Patients with Chronic Rhinosinusitis with Nasal Polyps and Positive Sinonasal Cultures. Int Arch ...

  4. Obstructive sleep apnea - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Dental Specialties · Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep ...

  5. Publications - Sherif A. El Nashar, M.B., B.Ch., M.S. - Mayo Clinic

    ... oral board examinees in different practice settings. Int Urogynecol J. 2019 Jul; 30 (7):1153-1161 Epub 2018 Apr 13. View PubMed; Hassani DB, Mangel JM ...

  6. Azacitidine and Sonidegib in Treating Patients With Myeloid Malignancies - Mayo Clinic

    Note: Hormonal contraception methods (e.g. oral, injected, implanted) are not allowed as it cannot be ruled out that the study drug decreases the effectiveness ...

  7. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

    Requires intermittent or chronic systemic (intravenous or oral) treatment with an antiherpetic drug (eg, acyclovir), other than intermittent topical use ...

  8. Diagnosis and management of patients with gastroparesis - Mayo Clinic

    In patients with refractory nausea and vomiting, oral or percutaneous jejunal nutrition may be necessary. Parenteral nutrition is associated with high risk ...

  9. Clinical trials - Oncology (Medical)

    ... oral chemotherapy regimens. Finally, this study will be the first to track the outcomes of subjects with disseminated B-cell Lymphoblastic Leukemia (B LLy) ...

  10. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    Use of anticoagulation therapy (e.g., warfarin, coumadin, or novel oral anticoagulants \[NOACs\]) or anti-platelet agents (e.g., thienopyridine) which cannot be ...